| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 12/12/2001 | EP1161440A1 Method for refolding molecules of polypeptides containing ig domains |
| 12/12/2001 | EP1086121A4 Non-enzymatic chemical amidation process |
| 12/12/2001 | EP0863797B1 Coded particles for process sequence tracking in combinatorial compound library preparation |
| 12/12/2001 | EP0809656B1 MONOCLONAL ANTIBODY SPECIFIC FOR beta-A4 PEPTIDE |
| 12/12/2001 | EP0787144B1 Major outer membrane protein cd of moraxella |
| 12/12/2001 | EP0662088B1 Inhibitor of collagen-stimulated platelet aggregation |
| 12/12/2001 | CN1326465A Methods of conversion of interferson isoforms and products thereof |
| 12/12/2001 | CN1326463A Method for continuously isolating active proteins |
| 12/11/2001 | US6329506 Template-assisted triple helical collagen-like structures |
| 12/11/2001 | US6329417 Hepatitis C inhibitor tri-pepitides |
| 12/11/2001 | US6329379 Oligopeptides for inhibiting hepatitis |
| 12/11/2001 | US6329147 Methods for detection of a triplet repeat block and a functional mismatch binding protein in a biological fluid sample |
| 12/11/2001 | US6329143 Providing a substrate having surface bearing multiple copies of a protective group removable on exposure to an electric field or electric current; applying electric field or current to substrate; exposing to protected monomer, repeating |
| 12/11/2001 | US6329139 Automated sorting system for matrices with memory |
| 12/06/2001 | WO2001092577A1 Extracellular drug-oligonucleotides chimeric molecules |
| 12/06/2001 | WO2001092557A2 Reaction block assembly for chemical synthesis |
| 12/06/2001 | WO2001092469A2 Phosphorylated polypeptides and uses related thereto |
| 12/06/2001 | WO2001092466A2 Chemical reagents for formation of disulfide bonds in peptides |
| 12/06/2001 | WO2001092311A2 Convergent combinatory peptide libraries and their use for vaccination against hepatitis c virus |
| 12/06/2001 | WO2001092304A2 Transporters and ion channels |
| 12/06/2001 | WO2001092293A2 Methods for identifying crystallization conditions for biomolecules |
| 12/06/2001 | WO2001057216A3 Method for the production of a protein |
| 12/06/2001 | WO2001047947A3 Method for the isolation of hydrophobic proteins |
| 12/06/2001 | WO2001025257A3 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 12/06/2001 | US20010049585 Computer predictions of molecules |
| 12/06/2001 | US20010049098 Method for producing structured, self-organized molecular monolayers of individual molecular species, in particular substance libraries. |
| 12/06/2001 | US20010048929 Novel multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 12/06/2001 | CA2410754A1 Phosphorylated polypeptides and uses related thereto |
| 12/06/2001 | CA2410084A1 Transporters and ion channels |
| 12/06/2001 | CA2409924A1 Convergent combinatory peptide libraries and their use for vaccination against hepatitis c virus |
| 12/05/2001 | EP1160256A2 Monoclonal antibody specific for beta-A4 peptide |
| 12/05/2001 | EP1159410A1 Method for rapidly obtaining crystals with desirable morphologies |
| 12/05/2001 | EP1159296A1 METHOD FOR PRODUCING CYCLO-(Asp-DPhe-NMeVal-Arg-Gly) |
| 12/05/2001 | EP1159295A1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 12/05/2001 | EP1159290A1 Separation method utilizing liquid-liquid partition |
| 12/05/2001 | EP1159289A1 Chemical synthesis and use of soluble membrane protein receptor domains |
| 12/05/2001 | EP0845003B1 Novel opioid peptides |
| 12/05/2001 | EP0763100A4 Method of purification of clostridium difficile toxin a and production of mono-specific antibodies |
| 12/05/2001 | EP0744901B1 Isolation of lactoferrin from milk |
| 12/05/2001 | CN1325405A Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 12/04/2001 | USRE37462 Protein sequence of the plant toxin gelonin |
| 12/04/2001 | US6326468 Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution |
| 12/04/2001 | CA2278883C Very large scale immobilized peptide synthesis |
| 12/04/2001 | CA2171882C Inhibitors of .beta.-amyloid protein production |
| 12/04/2001 | CA2062729C Interferon purification process |
| 12/04/2001 | CA2053829C Vaccines against equine herpesviruses and the preparation thereof |
| 12/04/2001 | CA2046880C Substituted alkylamide derivatives of teicoplanin |
| 12/04/2001 | CA2027635C Erythropoietin isoforms |
| 11/29/2001 | WO2001090420A1 Drug-oligonucleotides chimeric molecules |
| 11/29/2001 | WO2001090304A2 Nucleic acids, proteins, and antibodies |
| 11/29/2001 | WO2001090135A1 Drug-amino acids sequence chimeric molecules |
| 11/29/2001 | WO2001044272A3 Daptomycin analogs as antibacterial agents |
| 11/29/2001 | WO2001038347A3 Peptides having antiangiogenic activity |
| 11/29/2001 | US20010047086 High throughput screening of potential displacer molecules |
| 11/29/2001 | US20010047085 Adding to the protein solution a cyclodextrin in an amount sufficient to form a stable complex with the protein, lyophilizing, recovering lyophilized protein/cyclodextrin complex, heating complex to inactivate viruses |
| 11/29/2001 | US20010045384 Simulated activity of protein a displayed by ligands attached to a cellulose bead surface |
| 11/28/2001 | EP1157039A1 Collagen peptides modified by grafting mercapto functions, method for the production thereof and uses thereof as biomaterials |
| 11/28/2001 | EP1157030A1 Echinocandin/carbohydrate complexes |
| 11/28/2001 | EP1157029A1 Oligopeptide derivatives for the electrochemical measurement of protease activity |
| 11/28/2001 | EP1156835A2 Kit for radiolabeling proteins with yttrium-90 |
| 11/28/2001 | EP0804215B1 Template assembled synthetic protein |
| 11/28/2001 | CN1324366A Solid phase synthesis, whereby the solid phase consists of two different substrates |
| 11/28/2001 | CN1324258A Aglyco products and method of use |
| 11/28/2001 | CN1324251A Method of stimulating prosaposin receptor activity |
| 11/28/2001 | CN1324247A Process and materials for the repid detection of i(streptococcus pneumoniae) employing purified antigen-specific antibodies |
| 11/28/2001 | CN1323801A Simple ferredoxin separating process |
| 11/27/2001 | US6323326 Method of solubilizing, purifying, and refolding protein |
| 11/27/2001 | US6323323 Ligand-binding, dimerized polypeptide fusions |
| 11/27/2001 | US6323313 Genetically engineered binding protein for use in diagnosis, detection and treatment of vascular system thrombosis |
| 11/27/2001 | US6323180 Protease inhibitors; inhibit replication of hepatitis c virus |
| 11/27/2001 | US6323178 Beta-lipotropin methods |
| 11/27/2001 | US6323175 Composition comprising physiologically compatible liposome, hemoglobin encapsulated in liposome, and nitroxide encapsulated in liposome |
| 11/27/2001 | US6323017 Enzymatic polypeptide for prevention and treatment of asthma, exudative tympanitis, hemorrhagic colitis and adult respiratory distress syndrome |
| 11/27/2001 | US6322997 Protein recovery |
| 11/27/2001 | US6322779 Purified, unglycosylated endotoxin and pyrogen-free, high specific biological activity; two monomer structure |
| 11/27/2001 | CA2240392C Multimer forms of interleukin-16 (il-16), process for the preparation and use thereof |
| 11/27/2001 | CA2199941C Synthetic antibiotics |
| 11/27/2001 | CA2050644C Process for the purification of insulins by chromatography |
| 11/27/2001 | CA2021912C Erythropoietin (epo) peptides and antibodies directed against these |
| 11/22/2001 | WO2001088533A2 Lipid uptake assays |
| 11/22/2001 | WO2001088532A2 Improved assay techniques using nematode worms |
| 11/22/2001 | WO2001088160A2 Vectors for dna delivery |
| 11/22/2001 | WO2001088017A1 Polypeptide derivatives and nucleic acid carriers containing the same |
| 11/22/2001 | WO2001087925A2 Methods for refolding proteins containing free cysteine residues |
| 11/22/2001 | WO2001087922A2 Derivatisation of proteins in aqueous solution |
| 11/22/2001 | WO2001087920A2 Ligation method and reagents to form an amide bond |
| 11/22/2001 | WO2001087836A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same |
| 11/22/2001 | WO2001087835A1 Α crystalline form of perindopril tert-butylamine salt |
| 11/22/2001 | WO2001087468A1 Microfiltration using activated carbon |
| 11/22/2001 | WO2001032691A8 Hcv ns3 protease inhibitors |
| 11/22/2001 | US20010044521 Especially those present in inclusion bodies in bacterial hosts, by maintaining alkaline pH in presence of chaotrophic or reducing agents, and decreasing pH gradually over given time to induce renaturation; proteomics |
| 11/22/2001 | US20010044144 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 11/22/2001 | US20010044112 High throughput screening array containing porous material |
| 11/22/2001 | US20010042718 Affinity separation; filtration |
| 11/22/2001 | DE10024317A1 Electrophoretic separation of macromolecules, especially integral proteins, comprises preparing a membrane supported on a transparent substrate and applying electric field which fluctuates in strength or direction |
| 11/22/2001 | CA2408885A1 Vectors for dna delivery |
| 11/21/2001 | EP1156059A1 Selectively cleavable linkers based on a methionine group and an ester group |
| 11/21/2001 | EP1155035A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 11/21/2001 | EP1154857A1 System, method and computer program product for automated fluid or gas delivery |
| 11/21/2001 | EP1154848A2 Centrifuging apparatus and method for separation of liquid phases and organic synthesis |